XE
About
XENiOS AG developer of extracorporeal therapy systems., because the heart and the lungs are linked anatomically the right heart (ventricle) perfuses the lungs, while the left heart (ventricle) perfuses the body. No other company except XENIOS AG is offering minimally invasive disposable lung and heart therapies on one single platform.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 19 investors are based in Heilbronn, Baden-Wurttemberg, Germany.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech
- Location
- Heilbronn, Germany
Contact Information
linkedin.com/in/••••••••
Find more investors like XENiOS
Search Investors